Unmet needs and challenges in gastric cancer: the way forward
- PMID: 24656602
- DOI: 10.1016/j.ctrv.2014.03.002
Unmet needs and challenges in gastric cancer: the way forward
Abstract
Although the incidence of gastric cancer has fallen steadily in developed countries over the past 50 years, outcomes in Western countries remain poor, primarily due to the advanced stage of the disease at presentation. While earlier diagnosis would help to improve outcomes for patients with gastric cancer, better understanding of the biology of the disease is also needed, along with advances in therapy. Indeed, progress in the treatment of gastric cancer has been limited, mainly because of its genetic complexity and heterogeneity. As a result, there is an urgent need to apply precision medicine to the management of the disease in order to ensure that individuals receive the most appropriate treatment. This article suggests a number of strategies that may help to accelerate progress in treating patients with gastric cancer. Incorporation of some of these approaches could help to improve the quality of life and survival for patients diagnosed with the disease. Standardisation of care across Europe through expansion of the European Registration of Cancer Care (EURECCA) registry - a European cancer audit that aims to improve quality and decrease variation in care across the region - may also be expected to lead to improved outcomes for those suffering from this common malignancy.
Keywords: Drug development; Gastric cancer; Heterogeneity; Pathogenesis; Treatment.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of gastric cancer.Best Pract Res Clin Gastroenterol. 2007;21(6):965-81. doi: 10.1016/j.bpg.2007.10.003. Best Pract Res Clin Gastroenterol. 2007. PMID: 18070698 Review.
-
Palliative treatment and the role of surgical resection in gastric cancer.Dig Surg. 2013;30(2):174-80. doi: 10.1159/000351177. Epub 2013 Jul 18. Dig Surg. 2013. PMID: 23867595 Review.
-
Overview of adjuvant therapy for resected gastric cancer: differences in Japan and the United States.Semin Oncol. 2005 Dec;32(6 Suppl 9):S101-4. doi: 10.1053/j.seminoncol.2005.06.001. Semin Oncol. 2005. PMID: 16399444
-
Adjuvant and neoadjuvant therapy for gastric cancer.Semin Oncol. 1996 Jun;23(3):379-89. Semin Oncol. 1996. PMID: 8658222 Review.
-
Future perspectives for the development of chemotherapy for advanced gastric cancer: Japanese and global status.Pathobiology. 2011;78(6):334-42. doi: 10.1159/000321700. Epub 2011 Nov 18. Pathobiology. 2011. PMID: 22104205 Review.
Cited by
-
Multimodal treatment of gastric cancer in the west: Where are we going?World J Gastroenterol. 2015 Jul 14;21(26):7954-69. doi: 10.3748/wjg.v21.i26.7954. World J Gastroenterol. 2015. PMID: 26185368 Free PMC article. Review.
-
Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells.Int J Mol Sci. 2019 Jul 31;20(15):3736. doi: 10.3390/ijms20153736. Int J Mol Sci. 2019. PMID: 31370155 Free PMC article. Review.
-
Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer.Oncotarget. 2018 Apr 27;9(32):22332-22339. doi: 10.18632/oncotarget.24900. eCollection 2018 Apr 27. Oncotarget. 2018. PMID: 29854281 Free PMC article.
-
Down-regulation of CCNE1 expression suppresses cell proliferation and sensitizes gastric carcinoma cells to Cisplatin.Biosci Rep. 2019 Jun 4;39(6):BSR20190381. doi: 10.1042/BSR20190381. Print 2019 Jun 28. Biosci Rep. 2019. PMID: 31072916 Free PMC article.
-
Docetaxel, oxaliplatin, 5FU, and trastuzumab as first-line therapy in patients with human epidermal receptor 2-positive advanced gastric or gastroesophageal junction cancer: Preliminary results of a phase II study.Medicine (Baltimore). 2018 May;97(20):e10745. doi: 10.1097/MD.0000000000010745. Medicine (Baltimore). 2018. PMID: 29768350 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous